Department of Clinical Nursing, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.
Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
Nutrients. 2022 Jun 7;14(12):2368. doi: 10.3390/nu14122368.
(1) Background: The aim of this study was to assess the concentrations of selected elements in female patients with cancer of the reproductive organs, taking into account the stage of treatment. (2) Methods: The study sample consisted of 51 patients with advanced endometrial cancer and ovarian cancer, undergoing chemotherapy. The median age of the studied patients with endometrial cancer was 66.0 years (IQR: from 60.75 to 70.25), and with ovarian cancer―60.0 years (IQR: from 49.0 to 64.0). Each of the qualified women, after consent to participate in the study, had her blood drawn several times (before surgery, the first course of chemotherapy, the third course of chemotherapy, and the sixth course of chemotherapy) in order to determine serum levels of macro- and micronutrients (Na, Mg, Ca, Zn, P, Cu, Fe, Cd, Ni, and Sr). (3) Results: In the study group of patients with cancer of the reproductive tract, the concentrations of iron (<0.001), magnesium (0.038), sodium (0.014), and nickel (0.037) varied significantly over the course of the study. The analysis showed that the interaction between the stage of chemotherapy and the type of cancer had an effect on the concentrations of magnesium and cadmium (p < 0.05). (4) Conclusions: In the studied group of patients with ovarian and endometrial cancer, the applied chemotherapy significantly changed the concentrations of Fe, Na, and Ni, regardless of the type of tumor. Changes in Mg and Cd concentrations resulted from the interaction between the stage of chemotherapy and the type of cancer. The results of serum concentrations of selected elements in women with cancer of the reproductive organs may help understand the physiological changes resulting from the applied chemotherapy.
(1)背景:本研究旨在评估接受化疗的生殖器官癌症女性患者体内选定元素的浓度,同时考虑治疗阶段。(2)方法:研究样本包括 51 名晚期子宫内膜癌和卵巢癌患者。子宫内膜癌患者的中位年龄为 66.0 岁(IQR:60.75 至 70.25),卵巢癌患者的中位年龄为 60.0 岁(IQR:49.0 至 64.0)。每位符合条件的女性在同意参与研究后,多次采血(手术前、第一疗程化疗、第三疗程化疗和第六疗程化疗),以确定血清中宏量和微量元素(Na、Mg、Ca、Zn、P、Cu、Fe、Cd、Ni 和 Sr)的水平。(3)结果:在生殖系统癌症患者研究组中,铁(<0.001)、镁(0.038)、钠(0.014)和镍(0.037)的浓度在研究过程中差异显著。分析表明,化疗阶段与癌症类型之间的相互作用对镁和镉的浓度有影响(p<0.05)。(4)结论:在卵巢癌和子宫内膜癌患者研究组中,应用化疗会显著改变 Fe、Na 和 Ni 的浓度,而与肿瘤类型无关。Mg 和 Cd 浓度的变化是化疗阶段和癌症类型相互作用的结果。对生殖系统癌症女性血清中选定元素浓度的研究结果可能有助于了解应用化疗引起的生理变化。